Not only that, Bob, but hantavirus is also a Disease X candidate, possibly an mRNA vaccine side effect, and Moderna has been working with their University partner for 2 years on, (what else?) an mRNA vaccine for that indication.
We know that lenz is variant agnostic, and I agree with you in that lenz will also be effective in treating various cytokine-producing indications.
My last two posts to you were disappeared before they saw the light of day.